© 2017 by CELBRIDGE SDN BHD

Celbridge is currently engaged in clinical development of licensed proprietary PMSC® (Programmed Mesenchymal Stem Cells) platform technology. Utilising our scientific and industry partnership, Celbridge aims to address unmet medical needs through the development of stem cells as therapeutic agents in regenerative medicine.

IMPROVING QUALITY OF LIFE THROUGH SCIENCE

Prompt and Predictable Delivery
Reliable delivery of products as scheduled and on time to the right clients
Quality Services and Products

Every product batch is quality tested for cell morphology, cell viability, sterility and mycoplasma